Although we did not measure serum GLP-1 level in the experiment, decreased DPP-4 level, typically measured in the plasma, is another potential mechanism that GLP-1 may also have beneficial effects in the setting of kidney and cardiovascular disease. Here, GLP1R is linked to cardiovascular disorder.